Navigation Links
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Date:2/27/2008

PITTSBURGH, Feb. 27 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Jagdish Viswanath Dore' as CEO and Managing Director of Matrix Laboratories Limited. Mr. Dore' will assume the responsibilities of Rajiv Malik who became Executive Vice President and Head of Global Technical Operations for Mylan in October 2007 and has been serving as interim CEO for Matrix, a majority-owned subsidiary of Mylan. Mr. Malik will relocate to the United States in connection with his employment by Mylan.

Mr. Dore' joins Matrix after a distinguished 29 year career with Sandoz most recently as Managing Director and India Country Head. In this role, Mr. Dore' was responsible for all of Sandoz's operations in India including global development and manufacturing; local and export sales; day-to-day operations; and technical operations in the Asia Pacific region. He was previously responsible for business operations in the Asia Pacific cluster and involved in the startup of Novartis Enterprises Private Limited (now Sandoz), Novartis Consumer Health India Private Limited and Master Builders Technology India Private Limited, India.

Matrix Chairman and Mylan Vice Chairman and CEO Robert J. Coury said: "Jagdish's impressive industry reputation is well known, and I believe he will be a huge asset to Matrix as it continues to expand its integral role in support of Mylan's global platform. I have every confidence that Jagdish will ensure that Matrix continues its strong growth and supports Mylan in becoming the world's leading, fully-integrated generic pharmaceuticals company."

N. Prasad, Matrix's Vice Chairman, commented, "I have known Jagdish for some time, and I am absolutely delighted that he will be assuming Rajiv
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
2. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
3. Mylan Restores Availability of Generic Levothyroxine in Florida
4. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
5. Mylan Declares Quarterly Preferred Stock Dividend
6. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
7. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
8. Mylan Sets Date of 2008 Annual Meeting
9. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
10. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
11. Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Philadelphia, PA (PRWEB) November 24, 2014 ... care coordination and disease management services to health ... to implement Essette’s Medical Management software suite. ... SaaS platform in a program to reduce patients' ... includes Population Health Management, Care Management, Utilization Management, ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
(Date:11/23/2014)... Tbdress.com has recently announced that ... Nov. 28, 2014. The special offer will provide ladies many ... one of the world’s largest women’s dresses retailers, and its ... can enjoy great discounts on that day: Everything at Tbdress.com ... (for orders above $89). , People can use the following ...
(Date:11/23/2014)... 23, 2014 (HealthDay News) -- The holidays can be ... sensory overload can trigger major meltdowns, an expert says. ... best of circumstances, but when you have children with ... an occupational therapy professor at University of the Sciences ... "It,s best to let your hosts or visitors know ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are popular ... its new collection of power suppliers. Additionally, it has ... suppliers. All the new models come with big discounts, ... Dec. 20, 2014. , SWAccessControl.com has thousands of happy ... for a long time. It is very wise to ...
Breaking Medicine News(10 mins):Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2
... Technology Company Provides Interoperable ... CARROLLTON, Ga., July 9 Greenway Medical ... Week,s Capitol Hill,Technology Showcase, held in Washington D.C. ... one of the healthcare IT industry,s first and ...
... Summer, LAUREL, Miss., July 9 With the kids ... TV-watchers, Sanderson Farms,introduces the kick ,em off the couch for ... food and becoming more active., Studies show that over ... than they do in school or participating in any activity ...
... by the Wellcome Trust have identified a key mechanism that ... of blood vessels and avoid being destroyed by the body,s ... Cell , highlights an important potential new target for anti-malarial ... killing over a million people every year, mainly children and ...
... they believe to be the most accurate way of predicting ... obese mothers, according to a study in the UK-based journal ... the University of Rochester Strong Memorial Hospital in Rochester, New ... out of ten cases using the gestation-adjusted projection method (GAP). ...
... finds more than 350 common sets of genes in patients ... activity in breast cancer cells from younger patients could explain ... a younger age. , "We haven,t had a good reason ... study author Dr. Kimberly Blackwell, director of the clinical trials ...
... Laboratories,Inc. (Nasdaq: MLAB ) announced today that it ... annual list of the 100 fastest-growing,publicly held small companies ... public companies with annual revenues of less than $200 ... share, revenues, and stock,performance over the past three years. ...
Cached Medicine News:Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 2Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 3Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 4Health News:Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy 2Health News:Discovery of key malaria proteins could mean sticky end for parasite 2Health News:Research highlights problems of predicting birthweights in obese mothers 2Health News:Research highlights problems of predicting birthweights in obese mothers 3Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 2Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 3Health News:Mesa Laboratories, Inc. Named to Fortune Small Business Magazine's 2008 List 2
(Date:11/24/2014)... SAN DIEGO , Nov. 24, 2014  GlySens ... two-year, two million dollar grant from the National Institute ... division of the National Institutes of Health (NIH).  The ... the GlySens second generation ICGM™ long term implantable glucose ... are underway, and enrollment is expected to begin before ...
(Date:11/24/2014)... DEVON, England , Nov. 24, 2014 /PRNewswire/ ... https://www.facebook.com/PifflersUnited announced the release of results ... pain therapy device, in the self-management of fibromyalgia ... the area of worst pain, very significant clinically ... The 140 group members with fibromyalgia used ...
(Date:11/23/2014)... Nov. 23, 2014  Aurobindo Pharma USA ... Capsules, USP 300 mg 100-count bottles to the consumer ... some empty capsules. Empty capsules could result ... consequences that could range from no effect, short term ... epilepticus (long period seizures) that could be life-threatening. Aurobindo ...
Breaking Medicine Technology:GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2
... SB-509 to be Evaluated in Repeat-Dosing Study in Subjects ... Inc. (Nasdaq: SGMO ) announced today that it ... its drug, SB-509, in subjects,with ALS, a progressive, degenerative ... no cure., Sangamo,s drug, SB-509, is an injectable ...
... MIAMI and PALM BEACH, Fla., Sept. 2 ... of Miami and,Palm Beach announce a revolutionary new way ... of radiation. Prostate cancer is,the most common form of ... CEO, James G. Schwade, M.D., says, "for many cases,that ...
Cached Medicine Technology:Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5
... and O.R. staff work hard to protect ... intravasation. Manual methods are complicated, time-consuming, and ... II Fluid Management System for hysteroscopy, designed ... irrigation. It has been developed to provide ...
... These precision 4mL PYREX ... calibrated "To Contain" (TC - ... (TD - top line) to ... ware. Pipets are color-coded with ...
1000L...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: